Christopher Benoit
Directeur Général chez Alphazyme LLC
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Chad Decker | M | - |
Alphazyme LLC
 Alphazyme LLC Miscellaneous Commercial ServicesCommercial Services Part of Maravai Lifesciences Holdings, Inc., Alphazyme LLC is a company that specializes in the development and production of custom molecular biology enzymes at an industrial scale. The company is based in Jupiter, FL. The company collaborates with manufacturers of nucleic acid synthesis and detection platforms to produce high-quality and affordable enzymes for the growing markets of custom DNA and RNA molecules, genomic medicines, and genetic analysis. Alphazyme's mission is to be the world's premier partner for industrial-scale molecular biology enzymes. The company was founded by Christopher Benoit, who has been the CEO since incorporation. Alphazyme was acquired by Maravai Lifesciences Holdings, Inc. on February 22, 2023, for $145 million. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Noah Sachs | M | - |
New England Biolabs, Inc.
 New England Biolabs, Inc. Chemicals: SpecialtyProcess Industries New England Biolabs, Inc. produces and supplies reagents for the life science industry. The firm?s products include restriction endonucleases, PCR, qPCR and amplification technologies, DNA modifying enzymes, sample preparation for next generation sequencing, nucleic acid purification, DNA assembly, cloning and mutagenesis kits, genome editing, competent cells, markers and ladders, RNA reagents, gene expression, cellular analysis, epigenetics, protein tools, DNA plasmids, glycobiology, protein expression and purification technologies. The company was founded by Donald Comb in 1974 and is headquartered in Ipswich, MA. | 2 ans |
| Ian Clarke | M | - |
New England Biolabs, Inc.
New England Biolabs, Inc. Chemicals: SpecialtyProcess Industries New England Biolabs, Inc. produces and supplies reagents for the life science industry. The firm?s products include restriction endonucleases, PCR, qPCR and amplification technologies, DNA modifying enzymes, sample preparation for next generation sequencing, nucleic acid purification, DNA assembly, cloning and mutagenesis kits, genome editing, competent cells, markers and ladders, RNA reagents, gene expression, cellular analysis, epigenetics, protein tools, DNA plasmids, glycobiology, protein expression and purification technologies. The company was founded by Donald Comb in 1974 and is headquartered in Ipswich, MA. | - |
| Mike Melnick | M | - |
New England Biolabs, Inc.
New England Biolabs, Inc. Chemicals: SpecialtyProcess Industries New England Biolabs, Inc. produces and supplies reagents for the life science industry. The firm?s products include restriction endonucleases, PCR, qPCR and amplification technologies, DNA modifying enzymes, sample preparation for next generation sequencing, nucleic acid purification, DNA assembly, cloning and mutagenesis kits, genome editing, competent cells, markers and ladders, RNA reagents, gene expression, cellular analysis, epigenetics, protein tools, DNA plasmids, glycobiology, protein expression and purification technologies. The company was founded by Donald Comb in 1974 and is headquartered in Ipswich, MA. | 4 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 4 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Christopher Benoit
- Réseau Personnel
